We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Ablation of Prostate Cancer by Thermal Rods

By HospiMedica staff writers
Posted on 14 Mar 2001
Print article
A new technique for using heat to ablate prostate cancer suggests it may be used alone as an alternative treatment option or at a lower temperature in combination with radiation.

The technique involves the percutaneous placement of small magnetic alloy rods into the prostate gland. The rods are biocompatible implants, made of cobalt and palladium, which can be permanent. The patient with the implanted rods is then placed in an extracorporeal alternating magnetic field. As the rods resist the current, they heat but only to a temperature limit that was set during their manufacture.

In a study of the technique, researchers examined the effects of the rods placed within I cm of each other at various temperatures, finding that 70o C resulted in necrosis of cancerous prostate tissue. The treatment was well tolerated and could probably be performed in an outpatient setting, say the researchers. Since rods are permanently implanted, patients could be easily retreated when serum prostate-specific antigen (PSA) levels increase. The researchers also believe that treatment at hyperthermia temperatures in combination with radiation would be useful, since studies have shown heat enhances the effects of radiation.

The research team was headed by Robert D. Tucker, M.D., University of Iowa College of Medicine (Iowa City, IA, USA), whose earlier paper on the new technique was published in the August 2000 issue of the Journal of Endourology.
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Portable Ventilator
Oxivent Life
New
Multi-Parameter Patient Monitor
S90

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.